A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.

Keshavjee, S

A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. [electronic resource] - The Journal of thoracic and cardiovascular surgery Feb 2005 - 423-8 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

0022-5223

10.1016/j.jtcvs.2004.06.048 doi


Adolescent
Adult
Aged
Biomarkers--blood
Cardiopulmonary Bypass
Complement Inactivator Proteins--antagonists & inhibitors
Complement System Proteins--drug effects
Double-Blind Method
Female
Graft Rejection--etiology
Humans
Length of Stay
Lung Diseases--mortality
Lung Transplantation
Male
Middle Aged
North America
Oxygen Consumption--drug effects
Postoperative Complications--etiology
Receptors, Complement--antagonists & inhibitors
Reperfusion Injury--etiology
Respiration, Artificial
Surgical Wound Infection--etiology
Survival Analysis
Treatment Outcome